3[1]A. Dresse, C. Chevolet, D. Delapierre, et al. Pharmacokinetics of oral Dipyridamole (Persantine) and its effect platelet adenosine uptake in man [J] . Eur J Clin Pharmacol, 1982,23 (3): 229
4[3]Muller TH, Su CAPE, Weisenberger H, et al. Dypyridamole alone or combine wiht low-dose acetylsalicybc acid inhibits platelet aggregation in human whole blood ex vivo [J] . Br J Clin Pharmac, 1990, 30 (2): 179
5[4]Eva Nitelius, A Melander, Eloisabeth Wahlin-Boll. Phamacokinetic interaction of acetylsalicylic acid and dipyridamole [J] .Br. J. Clin. pharmacy, 1985, 19 (3): 379
6[6]ESPS Group European stroke prevention study [J] . stroke,1990, 21 (8): 1122
7[7]Forbes CD. European stroke prevention study 2: dipyridamole and acetylsalicylic add in the secondary prevention of stroke [J] . Int J clin. Pract, 1997, 51 (4): 205
8[8]Muller TH. Inhatition of thrombus formation by low-dose acetylsalicyclin acid, dipyridamole and tieir combination in a model of platelet-vessel wall interaction [J]. Neurology, 2001, 575(5 suppl 2): 8
9[9]Lenz TL, Hilleman DE. Aggrenox: a fixed-dose combination of aspirin and dipyridamole [J] . Ann pharmacother, 2000, 34(11): 1283
10[10]European stroke prevention study 2. Efficacy and safety data[J]. J Neurol sci, 1997, 151 (Suppl): 1
